Peer Review reports
From: Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
| Original Submission | ||
|---|---|---|
| 31 Dec 2008 | Submitted | Original manuscript |
| 30 Jan 2009 | Reviewed | Reviewer Report - Hong-Suk Song |
| 29 Mar 2009 | Reviewed | Reviewer Report - Kevin Kim |
| 21 May 2009 | Author responded | Author comments - John Nemunaitis |
| Resubmission - Version 2 | ||
| 21 May 2009 | Submitted | Manuscript version 2 |
| 20 Jun 2009 | Reviewed | Reviewer Report - Kevin Kim |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 29 Jul 2009 | Author responded | Author comments - John Nemunaitis |
| Resubmission - Version 4 | ||
| 29 Jul 2009 | Submitted | Manuscript version 4 |
| Publishing | ||
| 30 Jul 2009 | Editorially accepted | |
| 30 Jul 2009 | Article published | 10.1186/1471-2407-9-263 |
You can find further information about peer review here.